UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$1.19B |
| 2 |
Elevance Health
ELV
|
$275M |
| 3 |
Pinduoduo
PDD
|
$160M |
| 4 |
Visa
V
|
$159M |
| 5 |
Kanzhun
BZ
|
$148M |
Top Sells
| 1 |
Automatic Data Processing
ADP
|
$469M |
| 2 |
Amazon
AMZN
|
$297M |
| 3 |
Baidu
BIDU
|
$247M |
| 4 |
Microsoft
MSFT
|
$239M |
| 5 |
TC Energy
TRP
|
$214M |
Sector Composition
| 1 | Technology | 26.55% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Five Point Holdings
FPH
$397M
| $272K | ﹤0.01% |
69,628
-4,520
| -6% | -$17.7K |
|
2502
Ducommun
DCO
$1.35B
| $271K | ﹤0.01% |
6,293
-3,900
| -38% | -$168K |
|
2503
Tucows
TCX
$198M
| $269K | ﹤0.01% |
6,034
-3,366
| -36% | -$150K |
|
|
SOL
2504
Emeren Group
SOL
$96.5M
| $267K | ﹤0.01% |
56,200
+44,900
| +397% | +$213K |
|
2505
Ribbon Communications
RBBN
$707M
| $267K | ﹤0.01% |
87,797
-49
| -0.1% | -$149 |
|
2506
York Water
YORW
$447M
| $266K | ﹤0.01% |
+6,567
| New | +$266K |
|
|
KDNY
2507
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $264K | ﹤0.01% |
+15,109
| New | +$264K |
|
2508
American Vanguard Corp
AVD
$159M
| $263K | ﹤0.01% |
+11,775
| New | +$263K |
|
2509
Johnson Outdoors
JOUT
$423M
| $263K | ﹤0.01% |
4,300
-2,680
| -38% | -$164K |
|
2510
Thryv Holdings
THRY
$549M
| $262K | ﹤0.01% |
11,700
| – | – |
|
2511
Tredegar Corp
TG
$273M
| $259K | ﹤0.01% |
25,904
+4,697
| +22% | +$47K |
|
2512
Lands' End
LE
$439M
| $259K | ﹤0.01% |
24,368
| – | – |
|
2513
Protagonist Therapeutics
PTGX
$3.77B
| $258K | ﹤0.01% |
32,664
| – | – |
|
2514
Relmada Therapeutics
RLMD
$54.8M
| $257K | ﹤0.01% |
13,529
-10,591
| -44% | -$201K |
|
2515
Crinetics Pharmaceuticals
CRNX
$3.35B
| $256K | ﹤0.01% |
13,745
-1,276
| -8% | -$23.8K |
|
|
BTRS
2516
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $255K | ﹤0.01% |
51,130
-4,066
| -7% | -$20.2K |
|
|
AEVA
2517
Aeva Technologies
AEVA
$786M
| $254K | ﹤0.01% |
16,222
-4
| -0% | -$63 |
|
2518
Yext
YEXT
$1.1B
| $254K | ﹤0.01% |
53,092
-15,477
| -23% | -$74K |
|
|
ALX
2519
Alexander's
ALX
$1.2B
| $253K | ﹤0.01% |
1,140
| – | – |
|
2520
Zeta Global
ZETA
$4.5B
| $252K | ﹤0.01% |
+55,700
| New | +$252K |
|
|
DMTK
2521
DELISTED
DermTech, Inc. Common Stock
DMTK
| $252K | ﹤0.01% |
45,442
+31,542
| +227% | +$175K |
|
2522
Microvast
MVST
$829M
| $251K | ﹤0.01% |
113,213
+30,800
| +37% | +$68.4K |
|
2523
Veritone
VERI
$147M
| $251K | ﹤0.01% |
38,418
| – | – |
|
2524
Phibro Animal Health
PAHC
$1.6B
| $250K | ﹤0.01% |
13,078
| – | – |
|
2525
Outdoor Holding Company Common Stock
POWW
$169M
| $249K | ﹤0.01% |
64,800
-13,500
| -17% | -$52K |
|